FDA 483 - Adarsh Daswani, M.D. - February 07, 2025

An FDA inspection of Advanced Medical Research, Llc in La Palma, CA, identified significant deficiencies in clinical investigation conduct. The firm failed to follow the investigational plan by not administering required surveys for a subject. Additionally, the firm did not maintain adequate and accurate case histories, including failing to report multiple adverse events and serious adverse events in a timely manner.